Market Overview: In 2020, the global stem cells market reached a size of USD 10.13 Billion, and it is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 8.4% throughout the forecast period. Factors fueling this growth include advancements in stem cell research, a rise in the adoption of stem cell therapies for treating chronic and rare diseases, increased investment from pharmaceutical and biotechnology companies, and rapid progress in clinical trials for stem cell-based treatments. Moreover, developments in regenerative medicine, drug discovery based on patient-specific pluripotent cells, advancements in gene editing, and tissue engineering technologies are expected to further contribute to market revenue growth.
Get a sample copy of the Stem Cells Market report: https://www.reportsanddata.com/download-free-sample/2981
Characteristics of Stem Cells: Stem cells, found within the human body, are undifferentiated or progenitor cells capable of transforming into diverse cell lineages, ranging from muscle cells to brain cells. They possess the potential for sustained self-renewal and play a pivotal role in the regeneration and repair of tissues. There are two primary types of stem cells: pluripotent stem cells, able to differentiate into any cell type in the human body, and multipotent cells, which specialize in specific limited cell populations. Pluripotent stem cells are initially present in the embryo for a finite period before evolving into specialized multipotent stem cells, contributing to the formation of specific tissues in the body. In adults, alongside progenitor cells, stem cells contribute to the body's repair system and the regular turnover of regenerative organs, such as the skin. These attributes render stem cells valuable for potential applications in medical therapies.
Market Dynamics: Driving Factors:
- Advancement in Stem Cell Therapies: Stem cell therapies have gained prominence due to their ability to accelerate tissue regeneration through various mechanisms. Advanced tissue engineering techniques and their combination with stem cell technology have opened new avenues for treating diseases and producing tissue substitutes.
- Regenerative Medicine Development: Progress in regenerative medicine for diseases and disorders, along with gene editing and tissue engineering advancements, has significantly enhanced stem cell therapy and expanded its application scope.
Restraining Factors:
- Ethical Issues: Rapid advancements in biotechnology have given rise to ethical and policy concerns related to stem cell research. Safety and efficacy concerns associated with the induction of pluripotency and creation of pluripotent cell lines are expected to restrain market growth.
Key Takeaways: Product Outlook:
- The global stem cells market is segmented into adult stem cells, human embryonic stem cells, induced pluripotent stem cells (IPS cells), and very small embryonic-like stem cells. Human embryonic stem cells are expected to witness significant revenue growth, driven by their increasing use in regenerative medicine and tissue engineering applications.
Application Outlook:
- The market is divided into regenerative medicine and drug discovery & development. Regenerative medicine is projected to witness robust revenue growth, driven by the potential of stem cells in treating various diseases such as neurodegenerative diseases, diabetes, and immune system disorders.
Regional Outlook:
- North America is expected to account for the largest revenue share, attributed to increased investment in stem cell research, rapid adoption of stem cell-based therapies, favorable reimbursement policies, and the presence of advanced healthcare and research facilities.
- The Asia Pacific region is anticipated to experience significant revenue growth due to extensive research and development activities, rising awareness about the benefits of stem cell therapies, and approvals for clinical trials for regenerative medicine.
Competitive Landscape:
- The global stem cells market is fragmented, with key players such as Celgene Corporation, Virgin Health Bank, ReNeuron Group plc, Biovault Family, Mesoblast Ltd, Precious Cells International Ltd, Caladrius, Opexa Therapeutics, Inc., Neuralstem, Inc., and Pluristem. Companies are actively engaged in product development and strategic alliances to meet growing demand and establish a strong market presence.
Pipeline Analysis:
- Neuroplast's stem cell treatment for traumatic spinal cord injury showed positive results in Phase I, demonstrating the potential of using patient's own stem cells to prevent further loss of functions.
- Researchers from the Daegu Gyeongbuk Institute of Science and Technology developed a stem cell-based microbot, or "cellbot," capable of delivering stem cells to the brain through minimally invasive methods, offering potential applications in treating severe neurodegenerative disorders.
Segments Covered:
- The report segments the stem cells market based on product, technology, therapies, application, and region. The historical data and forecast cover the period from 2018 to 2028.
Market Report Scope:
- The market size was USD 10.13 Billion in 2020, with a forecasted CAGR of 8.4% from 2020 to 2028, reaching USD 19.13 Billion in 2028.
- Segmentation includes product types (adult stem cells, human embryonic stem cells, IPS cells, and very small embryonic-like stem cells), technology (cell acquisition, cell production, cryopreservation, and expansion & sub-culture), therapies (allogeneic stem cell therapy and autologous stem cell therapy), applications (regenerative medicine and drug discovery & development), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
- Key companies profiled include Celgene Corporation, Virgin Health Bank, ReNeuron Group plc, Biovault Family, Mesoblast Ltd, Precious Cells International Ltd, Caladrius, Opexa Therapeutics, Inc., Neuralstem, Inc., and Pluristem.
Customization Scope:
- The report offers 10 hours of free customization and expert consultation.
This comprehensive market report provides valuable insights into the global stem cells market, covering various facets, including current trends, drivers, restraints, and competitive landscape.
Explore Trending Reports:
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/2981
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian